Exact(7)
To describe the times associated with the morphological changes that occur in the embryo during preimplantation development based on the largest sample size described with time lapse.
Sampling and calculation of sample size described.
However, we cannot exclude selective reporting due to the relatively small sample size described in our case series.
Based on the sample size described below, we plan to implement the study in a total of 58 clusters (29 intervention and 29 control).
It is anticipated that for some practices the number of events may be too small to give precise estimates even with the sample size described above (e.g. magnesium sulfate for eclampsia).
With respect to the sample size described above, approximately 9200 patients will be required to evaluate the safety of alogliptin as the primary end point, detecting at least one adverse event occurring with an incidence of less than 0.05% with a probability of at least 99%.
Similar(53)
These estimates of variability allowed us to estimate 0.8 and 0.9 power to detect 5 and 10% allele frequency differences in the African American sample sizes described here.
Less than lifetime exposure and exposure misclassification will increase the sample sizes described in Table 3.
Minimum sample sizes: The minimum sample sizes described above were imposed to avoid highly underpowered studies leading to 'uninformative' null findings and/or publication bias.
Thus, for several reasons, the sample sizes described in Table 3 are conservative, and the sample sizes required to detect arsenic-induced cancer risks could actually be much greater.
To describe the events associated with the blastocyst formation and implantation that occur in embryos during preimplantation development based on the largest sample size ever described with time-lapse monitoring.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com